Smoking and therapeutic response to clozapine in patients with schizophrenia

Joseph Patrick McEvoy, Oliver Freudenreich, William H. Wilson

Research output: Contribution to journalArticle

158 Citations (Scopus)

Abstract

Background: Of patients with schizophrenia, 70 to 80% smoke. Nicotine corrects certain information processing and cognitive psychomotor deficits seen in many patients with schizophrenia. Clozapine, but not conventional antipsychotics, has been shown to correct some of these deficits. Methods: We assessed psychopathology and smoking in 70 patients with treatment refractory schizophrenia (55 smokers and 15 nonsmokers) at baseline when they were receiving conventional antipsychotics and again after they were switched to clozapine. Results: Smokers showed significantly greater therapeutic response to clozapine than nonsmokers. Smokers smoked less when treated with clozapine than when treated with conventional antipsychotics. Conclusions: Certain patients with schizophrenia have contributing pathophysiologic mechanisms that respond favorably to either nicotine or clozapine. Copyright (C) 1999 Society of Biological Psychiatry.

Original languageEnglish (US)
Pages (from-to)125-129
Number of pages5
JournalBiological Psychiatry
Volume46
Issue number1
DOIs
StatePublished - Jul 1 1999
Externally publishedYes

Fingerprint

Clozapine
Schizophrenia
Smoking
Antipsychotic Agents
Nicotine
Therapeutics
Psychopathology
Automatic Data Processing
Smoke

Keywords

  • Clozapine
  • Nicotine
  • Schizophrenia
  • Smoking

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Smoking and therapeutic response to clozapine in patients with schizophrenia. / McEvoy, Joseph Patrick; Freudenreich, Oliver; Wilson, William H.

In: Biological Psychiatry, Vol. 46, No. 1, 01.07.1999, p. 125-129.

Research output: Contribution to journalArticle

McEvoy, Joseph Patrick ; Freudenreich, Oliver ; Wilson, William H. / Smoking and therapeutic response to clozapine in patients with schizophrenia. In: Biological Psychiatry. 1999 ; Vol. 46, No. 1. pp. 125-129.
@article{460a67a487c24166a4e517c672620286,
title = "Smoking and therapeutic response to clozapine in patients with schizophrenia",
abstract = "Background: Of patients with schizophrenia, 70 to 80{\%} smoke. Nicotine corrects certain information processing and cognitive psychomotor deficits seen in many patients with schizophrenia. Clozapine, but not conventional antipsychotics, has been shown to correct some of these deficits. Methods: We assessed psychopathology and smoking in 70 patients with treatment refractory schizophrenia (55 smokers and 15 nonsmokers) at baseline when they were receiving conventional antipsychotics and again after they were switched to clozapine. Results: Smokers showed significantly greater therapeutic response to clozapine than nonsmokers. Smokers smoked less when treated with clozapine than when treated with conventional antipsychotics. Conclusions: Certain patients with schizophrenia have contributing pathophysiologic mechanisms that respond favorably to either nicotine or clozapine. Copyright (C) 1999 Society of Biological Psychiatry.",
keywords = "Clozapine, Nicotine, Schizophrenia, Smoking",
author = "McEvoy, {Joseph Patrick} and Oliver Freudenreich and Wilson, {William H.}",
year = "1999",
month = "7",
day = "1",
doi = "10.1016/S0006-3223(98)00377-1",
language = "English (US)",
volume = "46",
pages = "125--129",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Smoking and therapeutic response to clozapine in patients with schizophrenia

AU - McEvoy, Joseph Patrick

AU - Freudenreich, Oliver

AU - Wilson, William H.

PY - 1999/7/1

Y1 - 1999/7/1

N2 - Background: Of patients with schizophrenia, 70 to 80% smoke. Nicotine corrects certain information processing and cognitive psychomotor deficits seen in many patients with schizophrenia. Clozapine, but not conventional antipsychotics, has been shown to correct some of these deficits. Methods: We assessed psychopathology and smoking in 70 patients with treatment refractory schizophrenia (55 smokers and 15 nonsmokers) at baseline when they were receiving conventional antipsychotics and again after they were switched to clozapine. Results: Smokers showed significantly greater therapeutic response to clozapine than nonsmokers. Smokers smoked less when treated with clozapine than when treated with conventional antipsychotics. Conclusions: Certain patients with schizophrenia have contributing pathophysiologic mechanisms that respond favorably to either nicotine or clozapine. Copyright (C) 1999 Society of Biological Psychiatry.

AB - Background: Of patients with schizophrenia, 70 to 80% smoke. Nicotine corrects certain information processing and cognitive psychomotor deficits seen in many patients with schizophrenia. Clozapine, but not conventional antipsychotics, has been shown to correct some of these deficits. Methods: We assessed psychopathology and smoking in 70 patients with treatment refractory schizophrenia (55 smokers and 15 nonsmokers) at baseline when they were receiving conventional antipsychotics and again after they were switched to clozapine. Results: Smokers showed significantly greater therapeutic response to clozapine than nonsmokers. Smokers smoked less when treated with clozapine than when treated with conventional antipsychotics. Conclusions: Certain patients with schizophrenia have contributing pathophysiologic mechanisms that respond favorably to either nicotine or clozapine. Copyright (C) 1999 Society of Biological Psychiatry.

KW - Clozapine

KW - Nicotine

KW - Schizophrenia

KW - Smoking

UR - http://www.scopus.com/inward/record.url?scp=0033027553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033027553&partnerID=8YFLogxK

U2 - 10.1016/S0006-3223(98)00377-1

DO - 10.1016/S0006-3223(98)00377-1

M3 - Article

C2 - 10394482

AN - SCOPUS:0033027553

VL - 46

SP - 125

EP - 129

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 1

ER -